Tirzepatide

Tirzepatide (mounjaro)10mg Vial
Tirzepatide 20mg Certificate of Analysis (COA)
$85.00 – $130.00Price range: $85.00 through $130.00

For research use only. Not for human consumption.

Tirzepatide (LY3298176) is a synthetic 39-amino acid linear peptide and dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is the active compound in the medication Mounjaro. It features a C20 fatty diacid moiety attached via a hydrophilic linker at the Lys20 position, along with two α-aminoisobutyric acid (Aib) residues, designed for enhanced stability and receptor activity in laboratory settings.

This high-purity research-grade peptide is intended for in vitro and in vivo laboratory studies investigating incretin receptor signaling, metabolic pathways, and related biochemical processes.

  • Third Party Tested & Verified
  • Research Grade - 99% Purity
  • Orders Processed Daily
  • Flat Rate Express Shipping
  • Australia Wide Delivery
SKU: N/A
Category:

Description

Intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes.

Tirzepatide is a synthetic 39-amino acid peptide and dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is the active ingredient found in the brand name medication Mounjaro.

In laboratory research, Tirzepatide (often studied in the context of Mounjaro) is utilized to study incretin biology, receptor pharmacology, insulin secretion mechanisms, and metabolic regulation in cell-based and animal models. Researchers value its potent dual agonism for investigating synergistic effects on signaling pathways compared to single-receptor agonists.

Product is supplied as a lyophilized powder. 

Key Specifications:

  • Compound Name: Tirzepatide (LY3298176 - active ingredient of brand Mounjaro)
  • CAS Number: 2023788-19-2
  • Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
  • Molecular Weight: 4813.5 g/mol (average)
  • Peptide Length: 39 amino acids
  • Appearance: White to off-white lyophilized powder
  • Purity: ≥99% (HPLC) – typical research-grade batches >99.5%
  • Solubility: Soluble in water or DMSO (for laboratory reconstitution)
  • Storage: Lyophilized: -20°C. Reconstituted: 2–8°C (short term). Avoid repeated freeze-thaw cycles.
  • Source: Synthetic (solid-phase peptide synthesis)
  • Testing: HPLC, Mass Spectrometry (identity confirmation)

Research Applications Suitable for studies involving GIP and GLP-1 receptor activation, signal transduction, metabolic biochemistry, and peptide pharmacology in controlled laboratory environments.

Handling & Safety For laboratory use by qualified personnel. Refer to the provided Safety Data Sheet (SDS) for handling precautions, storage, and disposal. Use appropriate personal protective equipment.

Quality Assurance

  • Third-party testable upon request
  • Strict quality control to ensure consistency for reproducible research results
  • No animal-derived materials in synthesis

Long-term storage (recommended): Store the lyophilized powder at -20°C (standard laboratory freezer) in its original sealed vial. Under these conditions, high-purity Tirzepatide maintains stability for 12–24 months or longer.

Short-term storage:

  • For frequent access: 2–8°C (refrigerator) is acceptable for up to 3–6 months.
  • Avoid storage at room temperature for extended periods.

Legal & Compliance This product is sold strictly for research and scientific investigation purposes. The buyer is responsible for ensuring compliance with all local, state, and federal regulations regarding possession and use of research chemicals. Not for human consumption.

Not approved for therapeutic or diagnostic use.

Additional information

Size

10mg, 20mg
Research Focus

Glucose Regulation, Incretin Receptor Studies, Insulin Signaling, Metabolic Research, Weight Regulation Research